HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jones, R. E. Articles by Oliff, A. Search for Related Content PubMed PubMed Citation Articles by Jones, R. E. Articles by Oliff, A. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 22, 12782-12785, 08, 1990

Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein

RE Jones, RJ Wegrzyn, DR Patrick, NL Balishin, GA Vuocolo, MW Riemen, D Defeo- Jones, VM Garsky, DC Heimbrook and A Oliff
Department of Cancer Research, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.

Complex formation between the human papilloma virus type-16 E7 protein (HPV-16 E7) and the retinoblastoma suppressor protein (pRB) is believed to be important in the process of cellular transformation that leads to cervical carcinoma. Utilizing an in vitro solution assay as well as a plate binding assay that measures the association between HPV-16 E7 and pRB proteins, we have examined a series of synthetic HPV-16 E7 peptides. HPV-16 E7 peptides which lie between amino acid residues 14 and 32 were found to be potent inhibitors of E7/pRB binding. The minimal peptide structure that possessed full antagonist activity was N- acetyl-E7-(21-29)-peptide amide. This peptide inhibited 100% of E7/pRB binding and exhibited an IC50 of 40 nM in the plate binding assay. A purified beta-galactosidase-E7 fusion protein exhibited an IC50 of 2 nM in the same assay. These results suggest that other regions of the E7 molecule in addition to amino acids 21-29 may contributed to E7/pRB interaction. Analysis of E7-(20-29)-peptides containing single amino acid substitutions suggests that Cys24, Tyr23, Tyr25, Asp21, and Glu26 are important residues for maintaining maximal antagonist activity. This series of peptides should prove useful in analyzing the biological consequences of E7/pRB binding in HPV-infected cells.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Munger Clefts, grooves, and (small) pockets: The structure of the retinoblastoma tumor suppressor in complex with its cellular target E2F unveiled PNAS, March 4, 2003; 100(5): 2165 - 2167. [Full Text] [PDF]

				F. A. Dick and N. J. Dyson Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins J. Virol., May 13, 2002; 76(12): 6224 - 6234. [Abstract] [Full Text] [PDF]

				S. Miyake, W. R. Sellers, M. Safran, X. Li, W. Zhao, S. R. Grossman, J. Gan, J. A. DeCaprio, P. D. Adams, and W. G. Kaelin Jr. Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle Mol. Cell. Biol., December 1, 2000; 20(23): 8889 - 8902. [Abstract] [Full Text]

				W. R. MacLellan, G. Xiao, M. Abdellatif, and M. D. Schneider A Novel Rb- and p300-Binding Protein Inhibits Transactivation by MyoD Mol. Cell. Biol., December 1, 2000; 20(23): 8903 - 8915. [Abstract] [Full Text]

				A. Meléndez and I. Greenwald Caenorhabditis elegans lin-13, a Member of the LIN-35 Rb Class of Genes Involved in Vulval Development, Encodes a Protein With Zinc Fingers and an LXCXE Motif Genetics, July 1, 2000; 155(3): 1127 - 1137. [Abstract] [Full Text]

				F. A. Dick, E. Sailhamer, and N. J. Dyson Mutagenesis of the pRB Pocket Reveals that Cell Cycle Arrest Functions Are Separable from Binding to Viral Oncoproteins Mol. Cell. Biol., May 15, 2000; 20(10): 3715 - 3727. [Abstract] [Full Text]

				V. A. Ellsmore, A. P. Teoh, and A. Ganesan A High Throughput Enzyme-Linked Immunosorbent Assay for Inhibitors of the Interaction Between Retinoblastoma Protein and the Leu-X-Cys-X-Glu Motif J Biomol Screen, June 1, 1997; 2(4): 207 - 211. [Abstract] [PDF]

				M. Ewen, B Faha, E Harlow, and D. Livingston Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins Science, January 3, 1992; 255(5040): 85 - 87. [Abstract] [PDF]